Evoq Remedies Ltd

Statement of profit and loss

Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.

Earnings call

Evoq Remedies Ltd has not filed a concall transcript in the last 4 quarters.

Filings

11 shown · 11 published by the exchange

11 Jun 2026
Filing
Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
10 Jun 2026
Filing
Corporate Insolvency Resolution Process (CIRP)-Admission of application by Tribunal
30 May 2026
Filing
Integrated Filing (Finance) For The Half Year And Year Ended On 31St March, 2026
30 May 2026
Filing
Appointment Of M/S. Jay Pandya & Associates (FRN: S2024GJ963300), Company Secretaries, Ahmedabad, As Secretarial Auditor Of The Company For The Financial Year 2025-26.
30 May 2026
Results
Submission Of Audited Financial Results For The Half Year And Year Ended On 31St March, 2026 Along With Auditor'S Report.
30 May 2026
Board meeting
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday, 30Th May, 2026 And Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
27 May 2026
Board meeting
Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 27Th May, 2026 To 30Th May, 2026
11 May 2026
Board meeting
Board Meeting Intimation for Intimation For Rescheduling Of Board Meeting From 14Th May, 2026 To 27Th May, 2026
07 May 2026
Board meeting
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Thursday, 14Th May, 2026
30 Apr 2026
Filing
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
09 Apr 2026
Filing
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 11 Jun 2026.